C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) A61K 31/53 (2006.01) A61K 31/5377 (2006.01) A61K 31/55 (2006.01) A61P 3/10 (2006.01) A61P 11/06 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 487/08 (2006.01) C07D 491/113 (2006.01)
Patent
CA 2314008
A compound of the formula: (see formula I) or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are independently selected from hydrogen, halo, hydroxy, (C1- C4)alkyl, halo (C1-C4)alkyl and the like; R3 and R4 are independently selected from hydrogen, halo(C1-C10)alkyl, optionally substituted (C1-C6)alkyl and the like, or R3 and R4, together with the nitrogen atom to which they are attached, form an optionally substituted fully saturated, partially saturated or fully unsaturated heterocyclic ring; and R5 is (C4-C11)cycloalkyl and the like, has ORL1-receptor agonist activity, and are useful as analgesics or the like in mammalian subjects.
Bereskin & Parr
Pfizer Inc.
LandOfFree
2-benzimidazolylamine compounds as orl1-receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-benzimidazolylamine compounds as orl1-receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-benzimidazolylamine compounds as orl1-receptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490571